BioSpace News Archive

ChineseInvestors.com, Inc. recently announced that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (“CBD Biotech”), will participate in the 29th Vietnam International Trade Fair (Vietnam Expo) at the Hanoi International Exhibition Center (ICE) being held on April 10-13, 2019 in Hanoi.

Geom Therapeutics, Inc. announced upcoming data presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases in Amsterdam, Netherlands from April 13 to 16, 2019.

Soliton, Inc. summarized its efforts to conduct a proof of concept clinical trial for the treatment of cellulite based on Institutional Review Board approval of the study.

Robin Toft, Founder and CEO of Toft Group Executive Search, has been named a semifinalist in the EY Entrepreneur of The Year 2019 awards in San Diego.

Bluejay Diagnostics, Inc. is pleased to announce a new Cooperative Research & Development Agreement with the U.S. Naval Medical Research Center, Silver Spring, Md.

Mark A. Meltz, J.D. has joined the company as Senior Vice President, General Counsel and Sarah J. Spencer has joined the company as Vice President, Corporate Communications.

The Cellaca™ MX utilizes Nexcelom’s innovative cellular analysis technology for accurate cell sample concentration, viability and morphology measurements.

Catabasis Pharmaceuticals, Inc. announced that it will present edasalonexent program data, including from the Phase 2 MoveDMD trial and open-label extension, and the design of the Phase 3 PolarisDMD trial, at two major medical meetings in April: the 12th UK Neuromuscular Translational Research Conference and the 2019 Muscular Dystrophy Association Clinical and Scientific Conference.

Updated Results from Phase 1/2 Study to be Presented Today at the AACR Annual Meeting

Phase 1 results and new translational data supporting the development of BTRX-335140 for neurobehavioral disorders presented at the Kappa Therapeutics 2019 Conference